Zahl Per-Henrik, Mæhlen Jan
Division of Mental Health, Norwegian Institute of Public Health, Norway.
Tidsskr Nor Laegeforen. 2012 Feb 21;132(4):414-7. doi: 10.4045/tidsskr.11.0195.
In 2004 we wrote in Tidsskriftet that mammography screening resulted in massive over-diagnosis and over-treatment of breast cancer. Our study was criticised because we had only five years of follow-up time and did not take account of the fact that increased use of hormone replacement therapy could lead to more breast cancer. We have now been screening women for 14 years, and during a period when the use of hormones has fallen by 70 %.
Age-specific incidence rates, detection rates and interval rates for breast cancer in the period 1991-2009 have been computed for 40-79 year-old women. Incidence trends have been calculated using Poisson regression.
The incidence of breast cancer in the age group 40-49 was stable throughout the period, but rose by 50 % in the age group 50-69 years immediately after the start of screening. There was no significant reduction in the incidence of breast cancer in the age group 70-74. The number of new cases of breast cancer in the period increased from around 2000 to 2750. About 300 cases of ductal carcinoma in situ (DCIS) were also diagnosed. Today a total of some 1050 more women have been diagnosed than before screening started. Our calculations indicate that in the absence of screening, around 800 of these women would never have become breast cancer patients.
The figures from 14 years of mammography screening indicate that all increase in the incidence of breast cancer is due to over-diagnosis: findings of tumours that in the absence of screening would never have given rise to clinical illness.
2004年我们在《Tidsskriftet》杂志上撰文指出,乳腺钼靶筛查导致了乳腺癌的大量过度诊断和过度治疗。我们的研究受到了批评,因为我们只有五年的随访时间,且没有考虑到激素替代疗法使用增加可能导致更多乳腺癌这一事实。我们现在对女性进行了14年的筛查,且处于激素使用量下降了70%的时期。
计算了1991 - 2009年期间40 - 79岁女性乳腺癌的年龄别发病率、检出率和间隔期发病率。使用泊松回归计算发病率趋势。
40 - 49岁年龄组的乳腺癌发病率在整个时期保持稳定,但在筛查开始后,50 - 69岁年龄组的发病率立即上升了50%。70 - 74岁年龄组的乳腺癌发病率没有显著下降。该时期乳腺癌新发病例数从约2000例增加到2750例。还诊断出约300例导管原位癌(DCIS)。如今,与筛查开始前相比,总共多诊断出了约1050名女性。我们的计算表明,在没有筛查的情况下,这些女性中约800人永远不会成为乳腺癌患者。
14年乳腺钼靶筛查的数据表明,乳腺癌发病率的所有增加都归因于过度诊断:即发现了一些在没有筛查的情况下永远不会引发临床疾病的肿瘤。